LEO 142397
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LEO 142397, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese [Phase 1]